Clinical Trials on X-linked Severe Combined Immunodeficiency
Total 1627 results
-
Wuerzburg University HospitalKyowa Kirin, Inc.Completed
-
Amicus TherapeuticsCompletedFabry DiseaseJapan, Taiwan, Turkey, United States, Brazil
-
ShireNo longer available
-
CENTOGENE GmbH RostockShire Human Genetic Therapies, Inc.CompletedCerebrovascular AccidentAustria, Belgium, Croatia, Finland, France, Georgia, Germany, Ireland, Italy, Malta, Poland, Portugal, Spain, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedFabry DiseaseFrance, Poland, United States, Russian Federation, United Kingdom
-
Lysosomal and Rare Disorders Research and Treatment...SanofiUnknown
-
Amicus TherapeuticsCompletedOpen-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry DiseaseFabry DiseaseUnited States, Austria, United Kingdom, Argentina, Australia, Belgium, Brazil, Canada, Denmark, Egypt, France, Italy, Japan, Spain, Turkey
-
Genzyme, a Sanofi CompanyTerminatedFabry DiseaseAustria, Brazil, France, United States, Argentina, Belgium, Canada, Finland, Hungary, Norway, Poland, Spain, Taiwan, United Kingdom
-
Boston Children's HospitalWithdrawn
-
Hospices Civils de LyonCompleted
-
Kyowa Hakko Kirin Pharma, Inc.Kyowa Kirin Co., Ltd.CompletedX-linked HypophosphatemiaUnited States, Canada
-
University Hospital, BordeauxCompleted
-
Groupe Hospitalier Diaconesses Croix Saint-SimonTerminated
-
Peking Union Medical College HospitalUnknownX-linked HypophosphatemiaChina
-
Amicus TherapeuticsCompletedFabry DiseaseFrance, Austria, United States, Belgium, Japan, United Kingdom, Denmark, Brazil, Australia, Italy
-
Amicus TherapeuticsCompletedFabry DiseaseUnited States, Italy, Spain, Turkey, Brazil, Canada, United Kingdom, France, Poland, Australia, Egypt, Argentina, Denmark
-
Amicus TherapeuticsCompletedFabry DiseaseUnited States, Australia, France, United Kingdom, Brazil, Canada
-
Amicus TherapeuticsTerminatedFabry DiseaseAustralia, United States, Italy, Spain, Belgium, Turkey, Brazil, Argentina, United Kingdom, Denmark, France, Canada, Egypt
-
University Hospital, CaenUnknown
-
National Institute of Neurological Disorders and...National Institute of Neurological Disorders and Stroke@@@Shire Human Genetic...Completed
-
Genzyme, a Sanofi CompanyCompleted
-
Rigshospitalet, DenmarkCompletedFabry DiseaseDenmark
-
National Institute of Neurological Disorders and...Completed
-
Assistance Publique - Hôpitaux de ParisUnknown
-
Children's Hospital of Fudan UniversityNot yet recruiting
-
Westfälische Wilhelms-Universität MünsterChiesi GmbHRecruiting
-
ISU Abxis Co., Ltd.RecruitingFabry DiseaseKorea, Republic of
-
SanofiRecruiting
-
SanofiRecruitingFabry's DiseaseUnited States
-
Bio Sidus SARecruiting
-
Bahçeşehir UniversityNot yet recruitingDuchenne Muscular Dystrophy | Spinal Muscular Atrophy | Healthy Individuals
-
Hospital Clinico Universitario de SantiagoAlvaro Hermida (Co-IP); Susana Belen Bravo; Maria Teresa Cardoso; Cristobal Colon... and other collaboratorsRecruiting
-
Amicus TherapeuticsRecruiting
-
Amicus Therapeutics France SASCompletedFabry Disease | Anderson Fabry DiseaseFrance
-
University Health Network, TorontoOzmosis Research Inc.Completed
-
4D Molecular TherapeuticsActive, not recruiting
-
Bio Sidus SACompleted
-
TakedaCompleted
-
AVROBIOTerminatedFabry DiseaseUnited States, Australia, Brazil
-
National and Kapodistrian University of AthensCompletedFabry DiseaseGreece
-
Genzyme, a Sanofi CompanyCompleted
-
ProtalixChiesi Farmaceutici S.p.A.CompletedFabry DiseaseUnited States, Denmark, Belgium, United Kingdom, Norway, Italy, Czechia
-
ProtalixChiesi Farmaceutici S.p.A.CompletedFabry DiseaseUnited States, Spain, United Kingdom, Paraguay
-
Kyowa Kirin, Inc.Kyowa Kirin Co., Ltd.CompletedX-linked HypophosphatemiaUnited States, Korea, Republic of, Canada, Japan, France, Denmark
-
Chiesi Farmaceutici S.p.A.Iqvia Pty Ltd; ProtalixCompletedFabry DiseaseUnited States, Belgium, Denmark, Italy, United Kingdom
-
University of UtahGenzyme, a Sanofi CompanyCompletedFabry DiseaseUnited States